POSITIVE OUTCOMES OF THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH ECULIZUMAB THERAPY

被引：0

作者：

Villegas, A. ^{[1
]}

Urbano, A. ^{[2
]}

Cuevas, M. ^{[3
]}

Roncero, M. ^{[4
]}

Ruiz, B. ^{[5
]}

Cordoba, R. ^{[6
]}

Fernandez, F. ^{[7
]}

Toscano, R. ^{[8
]}

Gaya, A. ^{[2
]}

Bermejo, A. ^{[9
]}

Mardones, L. ^{[10
]}

Loureiro, C. ^{[11
]}

Moreno, D. ^{[12
]}

Alcala, A. ^{[13
]}

De La Iglesia, S. ^{[14
]}

Calvillo, M. ^{[15
]}

Menayo, M. ^{[16
]}

Gonzalez, A. ^{[1
]}

Arrizabalaga, B. ^{[17
]}

机构：

[1] Hosp Clin San Carlos, Hematol, Madrid, Spain

[2] Hosp Clin Barcelona, Hematol, Barcelona, Spain

[3] Hosp Gen Burgos, Hematol, Burgos, Spain

[4] Hosp Virgen de la Salud, Hematol, Toledo, Spain

[5] Hosp Ciudad Real, Hematol, Ciudad Real, Spain

[6] Hosp Infanta Sofia, Hematol, Madrid, Spain

[7] Hosp Univ Insular Gran Canaria, Hematol, Las Palmas Gran Canaria, Spain

[8] Hosp 12 Octubre, Hematol, Madrid, Spain

[9] Hosp Fuenlabrada, Hematol, Madrid, Spain

[10] Hosp Mostoles, Hematol, Madrid, Spain

[11] Hosp Meixoeiro, Hematol, Vigo, Spain

[12] Hosp Infanta Margarita Cabra, Hematol, Cordoba, Spain

[13] Hosp Jaen, Hematol, Jaen, Spain

[14] Hosp Dr Negrin, Hematol, Las Palmas Gran Canaria, Spain

[15] Hosp Navarra, Hematol, Pamplona, Spain

[16] Hosp Basurto, Hematol, Bilbao, Spain

[17] Hosp Cruces Barakaldo, Hematol, Bilbao, Spain

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B1440

引用

页码：579 / 579

页数：1

共 50 条

[41] Evaluation of the use of eculizumab for treatment of paroxysmal nocturnal hemoglobinuria
Maria de Andres, Ana
Sola, Nuria
Creus, Natalia
Codina, Carles
Ribas, Josep
PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 299 - 300
[42] The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
Yenerel, Mustafa Nuri
Erdem, Simge
Mastanzade, Metban
Nalcaci, Meliha
BLOOD, 2018, 132
[43] THERAPY FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
FREEMAN, H
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (23) : 1253 - 1254
[44] The complement inhibitor eculizumab improves anemia and reduces thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) patients
Risitano, A. M.
Hillmen, P.
Young, N. S.
Muus, P.
Duehrsen, U.
Schubert, J.
Schrezenmeier, H.
Szer, J.
Brodsky, R. A.
Hill, A.
Socie, G.
Maciejewski, J. P.
Rollins, S. A.
Rother, R. P.
Bell, L.
Marinelli, F.
Antonioli, E.
Lori, A. P.
Rodeghiero, F.
Zanella, A.
Luzzatto, L.
Rotoli, B.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
[45] Safety and efficacy of eculizumab with concomitant erythropoietin therapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)
Mojcik, C. F.
Young, N. S.
Luzzatto, L.
Socie, G.
Hillmen, P.
Brodsky, R. A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[46] KINETIC PARAMETERS OF COMPLEMENT ACTIVATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DURING ECULIZUMAB THERAPY
Tarasova, Yu, V
Klimova, O. U.
Andreeva, L. A.
Vasina, L. V.
Galebskaya, L., V
Babenko, E., V
Kulagin, A. D.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (02): : 126 - 137
[47] Cerebral arterial thrombosis in paroxysmal nocturnal hemoglobinuria
von Stuckrad-Barre, S
Berkefeld, J
Steckel, D
Sitzer, M
JOURNAL OF NEUROLOGY, 2003, 250 (06) : 756 - 757
[48] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
Fassett, Michael J.
Lopez, Adrian L. Hernandez
CASE REPORTS IN WOMENS HEALTH, 2021, 30
[49] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
Rodriguez-Garcia, Juan
Fernandez-Santos, Rafael
Antonio Garcia-Erce, Jose
MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
[50] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
Schrezenmeier, Hubert
Hoechsmann, Britta
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16

← 1 2 3 4 5 →